Journal
BIOTECHNOLOGY AND BIOENGINEERING
Volume 102, Issue 2, Pages 348-356Publisher
JOHN WILEY & SONS INC
DOI: 10.1002/bit.22192
Keywords
disposable technology; PAT; QbD; process consistency and validation; sensors; scale-up
Categories
Funding
- NSF
- NIH
- (Artisan, Baxter, DuPont, Fluorometrix, Genentech, Grace, Merck, Pfizer, Sartorius-Stedim Biotech)
Ask authors/readers for more resources
Increasing cost pressures are driving the rapid adoption of disposables in bioprocessing. While well ensconced in lab-scale operations, the lower operating/ validation costs at larger scale and relative ease of use are leading to these systems entering all stages and operations of a typical biopharmaceutical manufacturing process. Here, we focus on progress made in the incorporation of disposable equipment with sensor technology in bioprocessing throughout the development cycle. We note that sensor patch technology is mostly being adapted to disposable cell culture devices, but future adaptation to downstream steps is conceivable. Lastly, regulatory requirements are also briefly assessed in the context of disposables and the Process Analytical Technologies (PAT) and Quality by Design (QbD) initiatives.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available